Badreddin Edris, Chief Operating Officer at SpringWorks Therapeutics, Inc. (SWTX), sold 27,700 shares at $42.08 ($1.1M) on 2024-09-03, disclosed to the SEC on 2024-09-04.
Scheduled sale ($1.1M) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.11 | 12,300 | $493K | 43.6% |
| 2 | $41.12 | 4,620 | $190K | 16.8% |
| 3 | $41.12 | 4,620 | $190K | 16.8% |
| 4 | $42.08 | 3,080 | $130K | 11.4% |
| 5 | $42.08 | 3,080 | $130K | 11.4% |
| Total | $40.88 avg | 27,700 |
| $1.1M |
| 100% |
| Filing → |
| SWTX | SELL | 2025-02-12 | $1.6M | — | Filing → |
| SWTX | SELL | 2024-12-05 | $1.7M | — | Filing → |
| SWTX | SELL | 2024-06-05 | $1.6M | — | Filing → |